Diagnostic test accuracy of jolt accentuation for headache in acute meningitis in the emergency setting.
Acute Disease
Adolescent
Adult
Bias
Confidence Intervals
Critical Pathways
Disease Progression
Emergencies
False Negative Reactions
False Positive Reactions
Head Movements
/ physiology
Headache
/ cerebrospinal fluid
Humans
Leukocytosis
/ cerebrospinal fluid
Meningitis
/ cerebrospinal fluid
Physical Examination
/ methods
Rotation
Sensitivity and Specificity
Journal
The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747
Informations de publication
Date de publication:
11 06 2020
11 06 2020
Historique:
entrez:
12
6
2020
pubmed:
12
6
2020
medline:
25
7
2020
Statut:
epublish
Résumé
Meningitis is inflammation of the meninges, the layers that protect the brain and spinal cord. Acute meningitis is an emergent disease that develops over the course of hours to several days. Delay in treatment can lead to serious outcomes. Inflammation of the meninges is assessed by analysing cerebrospinal fluid. Identifying the pathogen in cerebrospinal fluid is another way to diagnose meningitis. Cerebrospinal fluid is collected by doing a lumbar puncture, which is an invasive test, and can be avoided if a physical examination excludes the diagnosis of meningitis. However, most physical examinations, such as nuchal rigidity, Kernig's test, and Brudzinski's test, are not sufficiently sensitive to exclude meningitis completely. Jolt accentuation of headache is a new and less well-recognised physical examination, which assesses meningeal irritation. It is judged as positive if the headache is exacerbated by rotating the head horizontally two or three times per second. A 1991 observational study initially reported high sensitivity of this examination to predict pleocytosis. Pleocytosis, an abnormally high cerebrospinal fluid sample white cell count, is an accepted indicator of nervous system infection or inflammation. Jolt accentuation of headache may therefore accurately rule out meningitis without the use of lumbar puncture. However, more recent cross-sectional studies have reported variable diagnostic accuracy. To estimate the diagnostic accuracy of jolt accentuation of headache for detecting acute meningitis in emergency settings. Secondary objectives: to investigate the sources of heterogeneity, including study population, patient condition, and types of meningitis. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), and Embase (Elsevier) to 27 April 2020. We searched ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform, and Ichushi-Web Version 5.0 to 28 April 2020. We included cross-sectional studies that assessed the diagnostic accuracy of jolt accentuation of headache for people with suspected meningitis in emergency settings. We included participants of any age and any severity of illness. Meningitis should be diagnosed with any reference standard, such as cerebrospinal fluid pleocytosis, proof of causative agents, or autopsy. Two review authors independently collated study data. We assessed methodological quality of studies using QUADAS-2 criteria. We used a bivariate random-effects model to determine summary estimates of sensitivity and specificity where meta-analysis was possible. We performed sensitivity analyses to validate the robustness of outcomes. We assessed the certainty of the evidence using the GRADE approach. We included nine studies (1161 participants). Five studies included only adults. Four studies included both adults and children; however, the proportion was not reported in three of these studies. The youngest child reported in the studies was aged 13 years. There was no study including only children. The reference standard was pleocytosis in eight studies, and the combination of pleocytosis and increased protein in the cerebrospinal fluid in one study. Two studies also used smear or positive culture of cerebrospinal fluid. Risk of bias and concern about applicability was high in the participant selection domain for all included studies and the consciousness subgroup. Overall, pooled sensitivity was 65.3% (95% confidence interval (CI) 37.3 to 85.6), and pooled specificity was 70.4% (95% CI 47.7 to 86.1) (very low-certainty evidence). We established the possibility of heterogeneity from visual inspection of forest plots. However, we were unable to conduct further analysis for study population, types of meningitis, and participants' condition, other than disturbance of consciousness (a secondary outcome). Amongst participants whose consciousness was undisturbed (8 studies, 921 participants), pooled sensitivity and specificity were 75.2% (95% CI 54.3 to 88.6) and 60.8% (95% CI 43.4 to 75.9), respectively (very low-certainty evidence). Jolt accentuation for headache may exclude diagnoses of meningitis in emergency settings, but high-quality evidence to support use of this test is lacking. Even where jolt accentuation of headache is negative, there is still the possibility of acute meningitis. This review identified the possibility of heterogeneity. However, factors that contribute to heterogeneity are incompletely understood, and should be considered in future research.
Sections du résumé
BACKGROUND
Meningitis is inflammation of the meninges, the layers that protect the brain and spinal cord. Acute meningitis is an emergent disease that develops over the course of hours to several days. Delay in treatment can lead to serious outcomes. Inflammation of the meninges is assessed by analysing cerebrospinal fluid. Identifying the pathogen in cerebrospinal fluid is another way to diagnose meningitis. Cerebrospinal fluid is collected by doing a lumbar puncture, which is an invasive test, and can be avoided if a physical examination excludes the diagnosis of meningitis. However, most physical examinations, such as nuchal rigidity, Kernig's test, and Brudzinski's test, are not sufficiently sensitive to exclude meningitis completely. Jolt accentuation of headache is a new and less well-recognised physical examination, which assesses meningeal irritation. It is judged as positive if the headache is exacerbated by rotating the head horizontally two or three times per second. A 1991 observational study initially reported high sensitivity of this examination to predict pleocytosis. Pleocytosis, an abnormally high cerebrospinal fluid sample white cell count, is an accepted indicator of nervous system infection or inflammation. Jolt accentuation of headache may therefore accurately rule out meningitis without the use of lumbar puncture. However, more recent cross-sectional studies have reported variable diagnostic accuracy.
OBJECTIVES
To estimate the diagnostic accuracy of jolt accentuation of headache for detecting acute meningitis in emergency settings. Secondary objectives: to investigate the sources of heterogeneity, including study population, patient condition, and types of meningitis.
SEARCH METHODS
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), and Embase (Elsevier) to 27 April 2020. We searched ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform, and Ichushi-Web Version 5.0 to 28 April 2020.
SELECTION CRITERIA
We included cross-sectional studies that assessed the diagnostic accuracy of jolt accentuation of headache for people with suspected meningitis in emergency settings. We included participants of any age and any severity of illness. Meningitis should be diagnosed with any reference standard, such as cerebrospinal fluid pleocytosis, proof of causative agents, or autopsy.
DATA COLLECTION AND ANALYSIS
Two review authors independently collated study data. We assessed methodological quality of studies using QUADAS-2 criteria. We used a bivariate random-effects model to determine summary estimates of sensitivity and specificity where meta-analysis was possible. We performed sensitivity analyses to validate the robustness of outcomes. We assessed the certainty of the evidence using the GRADE approach.
MAIN RESULTS
We included nine studies (1161 participants). Five studies included only adults. Four studies included both adults and children; however, the proportion was not reported in three of these studies. The youngest child reported in the studies was aged 13 years. There was no study including only children. The reference standard was pleocytosis in eight studies, and the combination of pleocytosis and increased protein in the cerebrospinal fluid in one study. Two studies also used smear or positive culture of cerebrospinal fluid. Risk of bias and concern about applicability was high in the participant selection domain for all included studies and the consciousness subgroup. Overall, pooled sensitivity was 65.3% (95% confidence interval (CI) 37.3 to 85.6), and pooled specificity was 70.4% (95% CI 47.7 to 86.1) (very low-certainty evidence). We established the possibility of heterogeneity from visual inspection of forest plots. However, we were unable to conduct further analysis for study population, types of meningitis, and participants' condition, other than disturbance of consciousness (a secondary outcome). Amongst participants whose consciousness was undisturbed (8 studies, 921 participants), pooled sensitivity and specificity were 75.2% (95% CI 54.3 to 88.6) and 60.8% (95% CI 43.4 to 75.9), respectively (very low-certainty evidence).
AUTHORS' CONCLUSIONS
Jolt accentuation for headache may exclude diagnoses of meningitis in emergency settings, but high-quality evidence to support use of this test is lacking. Even where jolt accentuation of headache is negative, there is still the possibility of acute meningitis. This review identified the possibility of heterogeneity. However, factors that contribute to heterogeneity are incompletely understood, and should be considered in future research.
Identifiants
pubmed: 32524581
doi: 10.1002/14651858.CD012824.pub2
pmc: PMC7386453
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
CD012824Informations de copyright
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Références
J Clin Epidemiol. 2005 Sep;58(9):882-93
pubmed: 16085191
Diagn Microbiol Infect Dis. 2006 Aug;55(4):275-8
pubmed: 16626906
Lancet Infect Dis. 2018 Sep;18(9):992-1003
pubmed: 30153934
Clin Neurol Neurosurg. 2010 Nov;112(9):752-7
pubmed: 20615607
Neurology. 2006 Jan 10;66(1):75-80
pubmed: 16401850
Cochrane Database Syst Rev. 2013 Jun 04;(6):CD004405
pubmed: 23733364
JAMA. 2006 Oct 25;296(16):2012-22
pubmed: 17062865
Med Hypotheses. 2014 Apr;82(4):490-2
pubmed: 24566235
J Clin Neonatol. 2013 Oct;2(4):166-8
pubmed: 24404527
Cephalalgia. 2006 Jun;26(6):684-90
pubmed: 16686907
Clin Infect Dis. 2002 Jul 1;35(1):46-52
pubmed: 12060874
Expert Opin Med Diagn. 2013 Jul;7(4):343-64
pubmed: 23721048
Turk J Emerg Med. 2016 Nov 24;17(1):29-31
pubmed: 28345071
Cochrane Database Syst Rev. 2019 Oct 21;10:CD011420
pubmed: 31633805
BMC Med Res Methodol. 2014 May 23;14:70
pubmed: 24884381
J Gen Intern Med. 2012 Jun;27 Suppl 1:S47-55
pubmed: 22648675
Rev Infect Dis. 1987 Nov-Dec;9(6):1187-92
pubmed: 3321367
Neurology. 2013 Jan 22;80(4):e36-9
pubmed: 23339213
Headache. 2017 Apr;57(4):586-592
pubmed: 28055104
Am J Emerg Med. 2014 May;32(5):477-8
pubmed: 24612592
Acta Paediatr. 2001 Jun;90(6):611-7
pubmed: 11440091
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
J Emerg Med. 2013 Oct;45(4):508-19
pubmed: 23910166
Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405
pubmed: 26362566
Lancet Infect Dis. 2007 Mar;7(3):191-200
pubmed: 17317600
South Med J. 1976 Apr;69(4):449-57
pubmed: 1265506
Emerg (Tehran). 2018;6(1):e8
pubmed: 29503833
Cochrane Database Syst Rev. 2020 Jun 11;6:CD012824
pubmed: 32524581
J Clin Microbiol. 1986 May;23(5):965-6
pubmed: 3711287
Am J Emerg Med. 2014 Jan;32(1):24-8
pubmed: 24139448
Acad Emerg Med. 2017 Jan;24(1):53-62
pubmed: 27473746
Headache. 1991 Mar;31(3):167-71
pubmed: 2071396
BMJ. 2008 May 17;336(7653):1106-10
pubmed: 18483053
Headache. 2018 Nov;58(10):1503-1510
pubmed: 30178879
N Engl J Med. 2004 Oct 28;351(18):1849-59
pubmed: 15509818
Neurol Clin. 2008 Aug;26(3):635-55, vii-viii
pubmed: 18657719
JAMA. 1999 Sep 15;282(11):1061-6
pubmed: 10493205
J Gen Fam Med. 2019 Jul 15;20(5):193-198
pubmed: 31516806
Rinsho Shinkeigaku. 2019 Sep 25;59(9):596-599
pubmed: 31474640
J Clin Epidemiol. 2006 Dec;59(12):1331-2; author reply 1332-3
pubmed: 17098577
Infect Dis Clin North Am. 1990 Dec;4(4):599-622
pubmed: 2277191
Semin Neurol. 2000;20(3):277-92
pubmed: 11051293
Clin Infect Dis. 1995 Apr;20(4):931-7
pubmed: 7795097
Lancet. 2017 Dec 17;388(10063):3036-3047
pubmed: 27265346
Lancet Neurol. 2005 Mar;4(3):160-70
pubmed: 15721826
Can J Infect Dis Med Microbiol. 2014 Sep;25(5):249-51
pubmed: 25371685
J Infect Dis. 1986 Sep;154(3):399-408
pubmed: 3734490
Handb Clin Neurol. 2010;96:31-49
pubmed: 20109673
Lancet Infect Dis. 2010 Nov;10(11):803-12
pubmed: 20822958
Am J Med. 2009 Jan;122(1):12-7
pubmed: 19114163
Headache. 2018 Apr;58(4):631
pubmed: 29611191
Headache. 2017 Nov;57(10):1618-1620
pubmed: 29124754
JAMA. 1999 Jul 14;282(2):175-81
pubmed: 10411200
Am J Med Sci. 2009 Aug;338(2):134-9
pubmed: 19680017
Am J Emerg Med. 2014 May;32(5):476-7
pubmed: 24655602
BMC Res Notes. 2017 Oct 30;10(1):540
pubmed: 29084605
Am J Emerg Med. 2013 Nov;31(11):1601-4
pubmed: 24070978